A Randomized, Open-label, Single Dose, 2-way Crossover Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
Latest Information Update: 18 Sep 2019
At a glance
- Drugs Lobeglitazone/metformin (Primary) ; Lobeglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 11 Dec 2015 New trial record